DENTSPLY SIRONA Q4 EPS Estimate Lowered by Leerink Partnrs

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Leerink Partnrs dropped their Q4 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Thursday, May 8th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings of $0.52 per share for the quarter, down from their prior forecast of $0.53. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2028 earnings at $2.59 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. During the same quarter in the previous year, the firm posted $0.42 EPS. The business’s revenue for the quarter was down 7.8% compared to the same quarter last year.

Other research analysts have also issued research reports about the company. Morgan Stanley lowered DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Piper Sandler reduced their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Barrington Research reduced their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Finally, Mizuho reduced their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.27.

DENTSPLY SIRONA Trading Down 0.6%

NASDAQ:XRAY opened at $15.81 on Monday. DENTSPLY SIRONA has a 12-month low of $12.16 and a 12-month high of $28.69. The firm has a market capitalization of $3.15 billion, a P/E ratio of -7.64, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business has a 50 day simple moving average of $14.36 and a 200 day simple moving average of $17.54.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.05%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.10%.

Insider Activity

In related news, Director Gregory T. Lucier bought 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.50% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Treasurer of the State of North Carolina raised its position in shares of DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock worth $1,686,000 after purchasing an additional 560 shares during the period. UMB Bank n.a. raised its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the period. Blue Trust Inc. raised its position in shares of DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares during the period. Quarry LP raised its position in shares of DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares during the period. Finally, Federated Hermes Inc. raised its position in shares of DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock worth $3,213,000 after purchasing an additional 915 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.